We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
A novel mutation in ROR2 led to the loss of function of ROR2 and inhibited the osteogenic differentiation capability of bone marrow mesenchymal stem cells (BMSCs).
- Authors
WENQI CHEN; XIAOYANG CHU; YANG ZENG; YOUSHENG YAN; YIPENG WANG; DONGLAN SUN; DONGLIANG ZHANG; JING ZHANG; KAI YANG
- Abstract
Background: Receptor tyrosine kinase-like orphan receptor 2 (ROR2) has a vital role in osteogenesis. However, the mechanism underlying the regulation of ROR2 in osteogenic differentiation is still poorly comprehended. A previous study by our research group showed that a novel compound heterozygous ROR2 variation accounted for the autosomal recessive Robinow syndrome (ARRS). This study attempted to explore the impact of the ROR2: c.904C>T variant specifically on the osteogenic differentiation of BMSCs. Methods: Coimmunoprecipitation (CoIP)-western blotting was carried out to identify the interaction between ROR2 and Wnt5a. Double-immunofluorescence staining was used for determining the expressions and co-localization of ROR2 and Wnt5a in bone marrow mesenchymal stem cells (BMSCs). Western blot (WB) analysis and quantitative reverse transcription polymerase chain reaction (RT-qPCR) were conducted to identify the expression levels of ROR2 in the BMSCs transfected with LV-shROR2 or LV-ROR2- c.904C>T. The alkaline phosphatase (ALP) activity was detected, and Alizarin Red S staining was done for evaluating the osteogenic differentiation of BMSCs. RT-qPCR was employed to identify the expression of the sphingomyelin synthase 1 (SMS1) mRNA in the BMSCs transfected with LV-shROR2 or LV-ROR2-c.904C>T and the mRNA expression levels of Runt-related transcription factor 2 (RUNX2), osteocalcin (OCN), and osteopontin (OPN). WB was performed to confirm the protein expressions of extracellular regulated protein kinases1 (ERK), P-ERK, Smad family member1/5/8 (Smad1/5/8), P-Smad1/5/8, P-P38, P38, RUNX2, OCN, and OPN in the BMSCs transfected with LV-shROR2/LV-ROR2-c.904C>T and sphingomyelin (SM). Results: The ROR2: c.904C>T mutant altered the subcellular localization of the ROR2 protein, which caused an impaired interaction between ROR2 and Wnt5a. The depletion of ROR2 restricted the osteogenic differentiation capability of BMSCs and downregulated the expression of SMS1. SM treatment could reverse the inhibition of osteoblastic differentiation in ROR2-depleted BMSCs. Conclusion: The findings of this work revealed that the ROR2: c.904C>T variant led to the loss of function of ROR2, which impaired the interaction between ROR2 and Wnt5a and also controlled the osteogenic differentiation capability of BMSCs. Furthermore, SM was revealed to be engaged in the osteoblastic differentiation of BMSCs regulated by ROR2, which renders SM a potential target in the therapy for ARRS.
- Subjects
GENETIC mutation; MESENCHYMAL stem cells; NUCLEAR receptors (Biochemistry); BONE growth; IMMUNOPRECIPITATION
- Publication
Biocell, 2023, Vol 47, Issue 7, p1561
- ISSN
0327-9545
- Publication type
Article
- DOI
10.32604/biocell.2023.028851